会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • LARGE-SCALE LATERAL NANOWIRE ARRAYS NANOGENERATORS
    • 大规模的横向纳米级阵列纳米器件
    • WO2012064571A2
    • 2012-05-18
    • PCT/US2011059044
    • 2011-11-03
    • GEORGIA TECH RES INSTWANG ZHONG LXU CHENQIN YONGZHU GUANGYANG RUSENHU YOUFANZHANG YAN
    • WANG ZHONG LXU CHENQIN YONGZHU GUANGYANG RUSENHU YOUFANZHANG YAN
    • H02N2/18
    • H01L41/316H02N2/18
    • In a method of making a generating device (100), a plurality of spaced apart elongated seed members (114) are deposited onto a surface of a flexible non-conductive substrate (110). An elongated conductive layer (118) is applied to a top surface and a first side of each seed member (114), thereby leaving an exposed second side opposite the first side. A plurality of elongated piezoelectric nanostructures (122) is grown laterally from the second side of each seed member (114). A second conductive material (126) is deposited onto the substrate (110) adjacent each elongated first conductive layer (118) so as to be coupled the distal end of each of the plurality of elongated piezoelectric nanostructures (122). The second conductive material (126) is selected so as to form a Schottky barrier between the second conductive material (126) and the distal end of each of the plurality of elongated piezoelectric nanostructures (122) and so as to form an electrical contact with the first conductive layer (118).
    • 在制造发生装置(100)的方法中,将多个间隔开的细长种子构件(114)沉积到柔性非导电衬底(110)的表面上。 细长导电层(118)被施加到每个种子构件(114)的顶表面和第一侧,从而留下与第一侧相对的暴露的第二侧。 多个细长的压电纳米结构(122)从每个种子构件(114)的第二侧横向生长。 邻近每个细长的第一导电层(118)将第二导电材料(126)沉积到衬底(110)上,以便耦合到多个细长的压电纳米结构(122)中的每一个的远端。 选择第二导电材料(126)以在第二导电材料(126)和多个细长压电纳米结构(122)中的每一个的远端之间形成肖特基势垒,以便形成与 第一导电层(118)。
    • 10. 发明申请
    • ANTIBODIES AGAINST CXCR4 AND METHODS OF USE THEREOF
    • 抗CXCR4的抗体及其使用方法
    • WO2006089141A2
    • 2006-08-24
    • PCT/US2006005691
    • 2006-02-15
    • DANA FARBER CANCER INST INCMARASCO WAYNE ASUI JIANHUAXU CHEN
    • MARASCO WAYNE ASUI JIANHUAXU CHEN
    • C07K16/2866A61K2039/505C07K16/005C07K2317/21C07K2317/622
    • The invention provides human monoclonal antibodies, scFv antibodies, scFv-Fc fusions, a dAb (domain antibodies), F ab , F ab' and F (ab')2 fragments, single chain antibodies and/or minibodies that specifically bind to CXCR4. Also provided are methods of treating and/or preventing a CXCR4 disease or disorder such as cancer and X4-tropic HIV-I infection as well as uses of such antibodies and antibody fragments in the manufacture of a medicament for the treatment or prevention of a CXCR4 disorder. The invention also provides methods of preventing diseases or disorders associated with CXCR4 function or expression. The invention further provides for the use of the antibodies (or fragments thereof) of the invention in the manufacture of a medicament for the prevention of diseases or disorders associated with CXCR4 expression. Also provided are methods of treating or preventing cancer metastasis in a patient suffering from a cancer involving tumor cells that express CXCR4. The invention also encompasses the use of such antibodies and antibody fragments in the manufacture of a medicament for the treatment or prevention of cancer metastasis. The invention also includes methods of treating or preventing cancer metastasis in a patient suffering from a hypoxic tumor, such as any solid tumor characterized by HIF- dependent CXCR4 activation. The antibodies and fragments disclosed herein can be used in the manufacture of a medicament for the prevention of cancer metastasis in a patient suffering from a hypoxic tumor. The invention additionally provides methods of mobilizing CD34 + stem cells from the bone marrow as wells methods of blocking chemotaxis of CXCR4-expressing cells in response to SDF-1. Also provided are methods of treating or preventing graft-versus-host disease as well as the use of the antibodies and fragments thereof in the manufacture of a medicament for the prevention or treatment of GVHD. Finally, the invention also provides methods of inhibiting the formation of new tumor blood vessels and/or inhibiting tumor cell angiogenesis.
    • 本发明提供了人单克隆抗体,scFv抗体,scFv-Fc融合蛋白,dAb(结构域抗体),F ab,ab F和ab F(ab' )2片段,与CXCR4特异性结合的单链抗体和/或微型抗体。 还提供了治疗和/或预防CXCR4疾病或病症例如癌症和X4向性HIV-1感染的方法以及这些抗体和抗体片段在制备用于治疗或预防CXCR4的药物中的用途 紊乱。 本发明还提供了预防与CXCR4功能或表达相关的疾病或病症的方法。 本发明还提供了本发明的抗体(或其片段)在制备用于预防与CXCR4表达相关的疾病或病症的药物中的用途。 还提供了治疗或预防患有涉及表达CXCR4的肿瘤细胞的癌症的患者的癌症转移的方法。 本发明还包括这些抗体和抗体片段在制备用于治疗或预防癌症转移的药物中的用途。 本发明还包括治疗或预防患有缺氧肿瘤的患者例如以HIF依赖性CXCR4活化为特征的任何实体瘤的癌症转移的方法。 本文公开的抗体和片段可以用于制造用于预防患有低氧肿瘤的患者中的癌症转移的药物。 本发明另外提供了从骨髓动员CD34 + / +干细胞以及阻断SDF-1响应CXCR4表达细胞的趋化性的方法。 还提供了治疗或预防移植物抗宿主病的方法以及抗体和其片段在制备用于预防或治疗GVHD的药物中的用途。 最后,本发明还提供了抑制新肿瘤血管形成和/或抑制肿瘤细胞血管生成的方法。